Thursday, February 21, 2019
    Latest

    IND

    Home IND
    Migraine
    IND

    Biohaven Announces Acceptance of Investigational New Drug IND Filing for Rimegepant...

    0
    China Immunotherapy
    IND

    China-based I-Mab Receives FDA IND Approval for Anti-GM-CSF Monoclonal Antibody TJM2

    0
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved